Clinical Trials Insight: 700025518

Next Previous
Trial Profile

Clinical Trials Insight: 700025518

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2007

At a glance

  • Drugs CX 717 (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Sponsors RespireRx Pharmaceuticals

    • Most Recent Events

    • 12 Oct 2007 Status changed from planning to discontinued.
    • 01 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top